Narrative review / 2017
Subclinical vitamin B12 deficiency affects 2.5% to 26% of the general population, with elderly individuals and those with low animal food intake at high risk.
This Primer reviews current knowledge on vitamin B12 deficiency, including its cellular roles in DNA synthesis, methylation, and mitochondrial metabolism. Subclinical B12 deficiency affects between 2.5% and 26% of the general population, although its clinical relevance is unclear. It can affect all ages, especially elderly individuals, as well as infants, children, adolescents, and women of reproductive age where intake of animal-derived foods is restricted. Diagnostic biomarkers include decreased circulating total B12 and transcobalamin-bound B12, alongside increased homocysteine and methylmalonic acid levels, with management relying on oral or parenteral supplementation.
- Study type
- Narrative review
- Who was studied
- General population across all ages, particularly elderly individuals
- What was measured
- Prevalence, causes, biomarkers, and management of vitamin B12 deficiency
THE PAPER
Vitamin B12 deficiency.
Green R, Allen LH, Bjørke-Monsen AL, Brito A, Guéant JL, Miller JW, Molloy AM, Nexo E, Stabler S, Toh BH, Ueland PM, Yajnik C. Nat Rev Dis Primers, 2017.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.